Breaking News

J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency

J&J announced it will "forgo implementation" of its 340B rebate proposal due to enforcement threats from HRSA.
Johnson & Johnson (J&J) notified the Health Resources and Services Administration (HRSA) this morning that it will drop its 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal

A bipartisan group of 188 House members sent HHS a letter urging action against J&J's 340B rebate proposal.
A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

HRSA to J&J: End 340B Rebate by Monday or Lose Access to Key Government Health Insurance Markets

HHS and HRSA sent J&J a Sept. 27 letter that again threatened tough enforcement action against the drugmaker's 340B rebate proposal.
The federal agency overseeing the 340B program has doubled down on its threat to terminate Johnson & Johnson’s (J&J’s) access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Senator Cassidy Extends 340B Inquiry to Two Major Pharmaceutical Manufacturers

Sen. Bill Cassidy (R-La.) has extended an ongoing 340B probe to two major drug manufacturers.
An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

HHS to J&J: End 340B Rebate Proposal Immediately or ‘Face Potential Consequences’—Including Termination from Federal Health Insurance Programs

HHS sent J&J a Sept. 17 letter demanding the drugmaker "immediately" cease its plan to implement a 340B rebate model.
The federal agency that oversees the 340B program today formally warned Johnson & Johnson (J&J) that it must “cease implementation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

J&J Announces Plans to Shift Certain 340B Discounts to Rebate Model, Prompting Fierce Backlash from Providers, Regulators

Johnson & Johnson announced it will convert two 340B drugs to a rebate model for hospitals.
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Highly Anticipated Bipartisan Senate 340B Overhaul Delayed Ahead of August Recess

The SUSTAIN 340B Act, a bipartisan Senate 340B program overhaul, has been delayed after its planned introduction on Aug. 1.
A long-awaited bipartisan senate bill to overhaul the 340B program will not be introduced prior to the August Congressional recess [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Missouri Become Eighth State to Enact 340B Contract Pharmacy Access Law After Governor Declines to Act on Bill

Missouri will become the eighth state to enact a 340B contract pharmacy access law when S.B.751 officially takes effect Aug. 28.
Missouri will become the eighth state to prohibit drug manufacturer 340B contract pharmacy restrictions after Gov. Mike Parson (R) announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Appeals Court Approves Drugmakers’ Federal 340B Contract Pharmacy Restrictions But Leaves Open Possibility of Enforcement Against Stricter Policies

A federal appeals court decided that the 340B statute does not prohibit all types of restrictions on 340B contract pharmacy use.
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Kansas Governor Rejects Provision to Delay New 340B Contract Pharmacy Protections

Kansas Gov. Laura Kelly (D) vetoed provisions of a bill that would have delayed a 340B contract pharmacy access law from taking effect.
A Kansas law that prohibits drugmaker 340B contract pharmacy restrictions is set to take effect July 1, as result of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live